Yes1 as a therapeutic target for her2-positive breast cancer after trastuzumab and trastuzumab-emtansine (T-dm1) resistance development

Miwa Fujihara, Tadahiko Shien, Kazuhiko Shien, Ken Suzawa, Tatsuaki Takeda, Yidan Zhu, Tomoka Mamori, Yusuke Otani, Ryo Yoshioka, Maya Uno, Yoko Suzuki, Yuko Abe, Minami Hatono, Takahiro Tsukioki, Yuko Takahashi, Mariko Kochi, Takayuki Iwamoto, Naruto Taira, Hiroyoshi Doihara, Shinichi Toyooka

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Yes1 as a therapeutic target for her2-positive breast cancer after trastuzumab and trastuzumab-emtansine (T-dm1) resistance development'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy

Engineering & Materials Science

Chemical Compounds